Robert Martin

Innovative strategies for targeting hidden weaknesses in cancer cells
Robert Martin
-

PROJECT LEADER
-

APPLICANT INSTITUTION
AND COUNTRYFundação GIMM - Gulbenkian Institute for Molecular Medicine, Lisboa, Portugal
-

DESCRIPTION
This research project explores a new and promising direction for cancer treatment by studying special structures that sometimes form when our cells read genetic informations. These structures can build up in cancer cells, causing harm if the body’s protective systems are not working properly. In many cancers, these natural protective tools are faulty, leaving cancer cells with a unique vulnerability.
The aim of this project is to find new medicines that increase the amount of these structures in cancer cells, making it difficult for them to survive. Healthy cells, which have their protective systems intact, can handle the extra stress, so only the cancer cells are affected. To achieve this, researchers use a clever method that lights up these structures in living cells, allowing scientists to observe changes directly and quickly test many possible medicines.
The research also uses advanced computer programs to help select the best candidates for testing, making the process quicker and more reliable. While the initial target is cancer, this method could also help in discovering treatments for other diseases, including those that affect the brain, the immune system, or are related to infections.
In summary, the project represents a step forward in developing safer, more effective ways to treat cancer. By focusing on a specific weakness in cancer cells and using new tools to find the best treatments, this project broadens the possibilities for future medicines and brings hope for improved therapies.
-

ORIGINAL
TITLEAI-Powered Screening of R-loop Modulators for Cancer Therapy
-

PROJECT
STAGEStage 1